Clinical Pharmacokinetics of Vemurafenib in BRAF-Mutated Melanoma Patients

  • C M Nijenhuis
  • , A D R Huitema
  • , C Blank
  • , J B A G Haanen
  • , J V van Thienen
  • , H Rosing
  • , J H M Schellens
  • , J H Beijnen

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)125-128
Number of pages4
JournalJournal of Clinical Pharmacology
Volume57
Issue number1
DOIs
Publication statusPublished - Jan 2017

Keywords

  • vemurafenib
  • pharmacokinetics
  • therapeutic drug monitoring
  • routine clinical care
  • exposure-response
  • LC-MS/MS

Cite this